Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trialYuan Zhang, Luo Zhang, Bing Yan et al.|EClinicalMedicine|2023Cited by 61
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialYan Zhao, Bo Chen, Xiaohua Tao et al.|Chinese Medical Journal|2023Cited by 40
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal PolypsShen Shen, Shui‐Hong Zhou, Bing Yan et al.|JAMA|2025Cited by 23
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trialMu Xian, Luo Zhang, Feng Lan et al.|Nature Communications|2025Cited by 5
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic DermatitisYan Zhao, Jianzhong Zhang, Litao Zhang et al.|Dermatitis|2025Cited by 1